Q2 2022 Earnings Estimate for Immunic, Inc. (NASDAQ:IMUX) Issued By Wedbush
Immunic, Inc. (NASDAQ:IMUX – Get Rating) – Wedbush raised their Q2 2022 earnings estimates for shares of Immunic in a report issued on Tuesday, May 10th. Wedbush analyst L. Moussatos now anticipates that the company will earn ($0.69) per share for the quarter, up from their prior forecast of ($0.77). Wedbush has a “Outperform” rating […]